Exposure Modification Orders Issued for VLN^® Cigarettes
The authorized products satisfy statutory requirements for modified risk tobacco products, including that they are appropriate to promote the public health and are expected to benefit the health of the population as a whole.
^{December 23, 2021}

Final Guidance: Tobacco Product User Fees: Responses to FAQs
FDA issues a final guidance that helps answer frequently asked questions around tobacco product user fees.
^{December 8, 2021}

FDA Authorizes Marketing of Four Oral Tobacco Products
Research shows a low likelihood that youth, non-smokers, or former smokers would initiate or reinitiate tobacco use with these products.
^{October 19, 2021}